ArticleProceedings of the National Academy of Sciences of the United States of America2022

Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms.

Novalia Pishesha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.